SCHEMBL28523429

SCHEMBL28523429

[c]1ccc(C2CCC(N3CCOCC3)C2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 1/20 0.46
HRH3 Q9Y5N1 4/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
KDM1A O60341 1/20 0.42
MAOB P27338 1/20 0.42
PRCP P42785 2/20 0.38
KCNH2 Q12809 2/20 0.38
IRAK4 Q9NWZ3 2/20 0.38
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
HPGD P15428 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL3 Q96JM7 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
OPRL1 P41146 2/20 0.35
ABL1 P00519 1/20 0.35
LCK P06239 1/20 0.35
LYN P07948 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2466664 0.90 HRH3 (0.50) SLC6A4HRH3CYP3A4CYP2C9KDM1A
SCHEMBL4612961 0.75 L3MBTL3 (0.56) HRH3L3MBTL3L3MBTL1OPRL1
SCHEMBL27709432 0.75 CYP2D6 (0.65) HRH3CYP3A4CYP2C9KDM1AMAOB
SCHEMBL2383142 0.73 KCNH2 (0.37) HRH3CYP3A4CYP2C9KCNH2SMN1; SMN2
SCHEMBL2874610 0.72 HRH3 (0.52) HRH3CYP3A4CYP2C9KDM1AMAOB
SCHEMBL10836464 0.72 HRH3 (0.52) HRH3CYP3A4CYP2C9IRAK4CYP2D6
SCHEMBL2876268 0.72 HRH3 (0.52) HRH3CYP3A4CYP2C9KDM1AMAOB
SCHEMBL519944 0.72 HRH3 (0.52) HRH3CYP3A4CYP2C9KDM1AMAOB
SCHEMBL28770195 0.69 HRH3 (0.44) HRH3CYP3A4CYP2C9KDM1AMAOB
SCHEMBL10306270 0.69 SLC6A4 (0.50) SLC6A4PRCPKCNH2IRAK4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112368285-A Pyrrolotriazine compounds and methods of inhibiting TAM kinase 希洛斯医药品股份有限公司 2021-02-12 CN disclosed